Between five and 10% of cancer cases are inherited. Individuals with a genetic predisposition for developing the disease will have a far higher chance of developing cancer within their lifetime and at an earlier age.
Genetic testing can help determine whether a family has a hereditary cancer predisposition syndrome. Individuals who have genetically higher risks to develop certain cancers are recommended to follow high-risk cancer surveillance and management.
The Clinical Cancer Genetics Program can coordinate genetic testing and high-risk cancer surveillance for individuals and their families with hereditary cancer syndromes.
Save the Date: Upcoming Symposium
The 9th Annual Hereditary Cancer Symposium for Health Care Providers will be held April 10–11, 2026.